venBio Global Strategic Fund, L.P. - 02 Feb 2026 SCHEDULE 13D/A Report for ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO)

Filing Manager
venBio Global Strategic Fund, L.P.
Reporting Manager
GOODMAN COREY S
Security
ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share
Symbol
ALXO
Shares outstanding
131,635,490 shares
Disclosed Ownership
13,163,549 shares
Ownership
10%
Form type
SCHEDULE 13D/A
Filing time
04 Feb 2026, 21:03:01 UTC
Date of event
02 Feb 2026
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
venBio Global Strategic Fund, L.P. 3.4% 4,431,600 0 4,431,600 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partners 0001504130
venBio Global Strategic Fund II L.P. 6.4% 8,453,038 0 8,453,038 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partners 0001634632
venBio Global Strategic GP, L.P. 3.4% 4,431,600 0 4,431,600 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner 0001770834
venBio Global Strategic GP II, L.P. 6.4% 8,453,038 0 8,453,038 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner 0001729409
venBio Global Strategic GP, Ltd. 3.4% 4,431,600 0 4,431,600 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors 0001770835
venBio Global Strategic GP II, Ltd. 6.4% 8,453,038 0 8,453,038 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors 0001729408
Adelman Robert J 9.9% 12,984,044 99,406 12,884,638 /s/ David Pezeshki David Pezeshki, as attorney-in-fact 0001329161
GOODMAN COREY S 10% 13,163,549 111,541 13,052,008 /s/ David Pezeshki David Pezeshki, as attorney-in-fact 0001278411